Loading…

Differential local and systemic regulation of the murine chemokines KC and MIP2

We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or M...

Full description

Saved in:
Bibliographic Details
Published in:Shock (Augusta, Ga.) Ga.), 2001-04, Vol.15 (4), p.278-284
Main Authors: CALL, Douglas R, NEMZEK, Jean A, EBONG, Samuel J, BOLGOS, Gerald R, NEWCOMB, David E, WOLLENBERG, Gordon K, REMICK, Daniel G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513
cites
container_end_page 284
container_issue 4
container_start_page 278
container_title Shock (Augusta, Ga.)
container_volume 15
creator CALL, Douglas R
NEMZEK, Jean A
EBONG, Samuel J
BOLGOS, Gerald R
NEWCOMB, David E
WOLLENBERG, Gordon K
REMICK, Daniel G
description We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was >50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.
doi_str_mv 10.1097/00024382-200115040-00005
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00024382_200115040_00005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11303726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</originalsourceid><addsrcrecordid>eNpFkE1PAyEURYnR2Fr9C4bE9SjwoMDS1K_GmrrQ9YRhwI7ORwPTRf-9dFrrBi7knpeXgxCm5JYSLe8IIYyDYhkjhFJBOMnSFxEnaEzF7iEoP02ZSMgYMDZCFzF-D5CW52hEKRCQbDpGy4fKexdc21emxnVn02naEsdt7F1TWRzc16Y2fdW1uPO4XzncbELVOmxXrul-Uor4dTYwb_N3donOvKmjuzrcE_T59Pgxe8kWy-f57H6RWVC6z1ShikKUxqcNFXjqhPfgFPCpEMpqoby0pTOaGU751OjSKANSaiIkcCUoTJDaz7WhizE4n69D1ZiwzSnJd47yP0f50VE-OEro9R5db4rGlf_gQUoq3BwKJiYfPpjWVvHY08AkE_ALhARtKg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><source>Freely Accessible Journals</source><creator>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</creator><creatorcontrib>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</creatorcontrib><description>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was &gt;50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</description><identifier>ISSN: 1073-2322</identifier><identifier>EISSN: 1540-0514</identifier><identifier>DOI: 10.1097/00024382-200115040-00005</identifier><identifier>PMID: 11303726</identifier><language>eng</language><publisher>Augusta, GA: BioMedical Press</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blotting, Western ; Chemokine CXCL1 ; Chemokine CXCL2 ; Chemokines - genetics ; Chemokines - metabolism ; Chemokines - pharmacology ; Chemokines, CXC ; Chemotactic Factors - genetics ; Chemotactic Factors - metabolism ; Chemotactic Factors - pharmacology ; Chemotaxis, Leukocyte - drug effects ; Emergency and intensive care: infection, septic shock ; Enzyme-Linked Immunosorbent Assay ; Gene Expression Regulation ; Glycogen - toxicity ; Growth Substances - genetics ; Growth Substances - metabolism ; Growth Substances - pharmacology ; Intensive care medicine ; Intercellular Signaling Peptides and Proteins ; Interleukin-6 - analysis ; Leukocyte Elastase - secretion ; Lipopolysaccharides - pharmacology ; Macrophage Activation - drug effects ; Macrophages, Peritoneal - secretion ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Models, Animal ; Neutrophils - drug effects ; Peritonitis - chemically induced ; Peritonitis - genetics ; Peritonitis - immunology ; Peritonitis - metabolism ; Rabbits ; Recombinant Fusion Proteins - pharmacology ; Thioglycolates - toxicity ; Tumor Necrosis Factor-alpha - analysis</subject><ispartof>Shock (Augusta, Ga.), 2001-04, Vol.15 (4), p.278-284</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=932725$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11303726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CALL, Douglas R</creatorcontrib><creatorcontrib>NEMZEK, Jean A</creatorcontrib><creatorcontrib>EBONG, Samuel J</creatorcontrib><creatorcontrib>BOLGOS, Gerald R</creatorcontrib><creatorcontrib>NEWCOMB, David E</creatorcontrib><creatorcontrib>WOLLENBERG, Gordon K</creatorcontrib><creatorcontrib>REMICK, Daniel G</creatorcontrib><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><title>Shock (Augusta, Ga.)</title><addtitle>Shock</addtitle><description>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was &gt;50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Chemokine CXCL1</subject><subject>Chemokine CXCL2</subject><subject>Chemokines - genetics</subject><subject>Chemokines - metabolism</subject><subject>Chemokines - pharmacology</subject><subject>Chemokines, CXC</subject><subject>Chemotactic Factors - genetics</subject><subject>Chemotactic Factors - metabolism</subject><subject>Chemotactic Factors - pharmacology</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Emergency and intensive care: infection, septic shock</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Gene Expression Regulation</subject><subject>Glycogen - toxicity</subject><subject>Growth Substances - genetics</subject><subject>Growth Substances - metabolism</subject><subject>Growth Substances - pharmacology</subject><subject>Intensive care medicine</subject><subject>Intercellular Signaling Peptides and Proteins</subject><subject>Interleukin-6 - analysis</subject><subject>Leukocyte Elastase - secretion</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophages, Peritoneal - secretion</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Models, Animal</subject><subject>Neutrophils - drug effects</subject><subject>Peritonitis - chemically induced</subject><subject>Peritonitis - genetics</subject><subject>Peritonitis - immunology</subject><subject>Peritonitis - metabolism</subject><subject>Rabbits</subject><subject>Recombinant Fusion Proteins - pharmacology</subject><subject>Thioglycolates - toxicity</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><issn>1073-2322</issn><issn>1540-0514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkE1PAyEURYnR2Fr9C4bE9SjwoMDS1K_GmrrQ9YRhwI7ORwPTRf-9dFrrBi7knpeXgxCm5JYSLe8IIYyDYhkjhFJBOMnSFxEnaEzF7iEoP02ZSMgYMDZCFzF-D5CW52hEKRCQbDpGy4fKexdc21emxnVn02naEsdt7F1TWRzc16Y2fdW1uPO4XzncbELVOmxXrul-Uor4dTYwb_N3donOvKmjuzrcE_T59Pgxe8kWy-f57H6RWVC6z1ShikKUxqcNFXjqhPfgFPCpEMpqoby0pTOaGU751OjSKANSaiIkcCUoTJDaz7WhizE4n69D1ZiwzSnJd47yP0f50VE-OEro9R5db4rGlf_gQUoq3BwKJiYfPpjWVvHY08AkE_ALhARtKg</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>CALL, Douglas R</creator><creator>NEMZEK, Jean A</creator><creator>EBONG, Samuel J</creator><creator>BOLGOS, Gerald R</creator><creator>NEWCOMB, David E</creator><creator>WOLLENBERG, Gordon K</creator><creator>REMICK, Daniel G</creator><general>BioMedical Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010401</creationdate><title>Differential local and systemic regulation of the murine chemokines KC and MIP2</title><author>CALL, Douglas R ; NEMZEK, Jean A ; EBONG, Samuel J ; BOLGOS, Gerald R ; NEWCOMB, David E ; WOLLENBERG, Gordon K ; REMICK, Daniel G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Chemokine CXCL1</topic><topic>Chemokine CXCL2</topic><topic>Chemokines - genetics</topic><topic>Chemokines - metabolism</topic><topic>Chemokines - pharmacology</topic><topic>Chemokines, CXC</topic><topic>Chemotactic Factors - genetics</topic><topic>Chemotactic Factors - metabolism</topic><topic>Chemotactic Factors - pharmacology</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Emergency and intensive care: infection, septic shock</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Gene Expression Regulation</topic><topic>Glycogen - toxicity</topic><topic>Growth Substances - genetics</topic><topic>Growth Substances - metabolism</topic><topic>Growth Substances - pharmacology</topic><topic>Intensive care medicine</topic><topic>Intercellular Signaling Peptides and Proteins</topic><topic>Interleukin-6 - analysis</topic><topic>Leukocyte Elastase - secretion</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophages, Peritoneal - secretion</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Models, Animal</topic><topic>Neutrophils - drug effects</topic><topic>Peritonitis - chemically induced</topic><topic>Peritonitis - genetics</topic><topic>Peritonitis - immunology</topic><topic>Peritonitis - metabolism</topic><topic>Rabbits</topic><topic>Recombinant Fusion Proteins - pharmacology</topic><topic>Thioglycolates - toxicity</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CALL, Douglas R</creatorcontrib><creatorcontrib>NEMZEK, Jean A</creatorcontrib><creatorcontrib>EBONG, Samuel J</creatorcontrib><creatorcontrib>BOLGOS, Gerald R</creatorcontrib><creatorcontrib>NEWCOMB, David E</creatorcontrib><creatorcontrib>WOLLENBERG, Gordon K</creatorcontrib><creatorcontrib>REMICK, Daniel G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Shock (Augusta, Ga.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CALL, Douglas R</au><au>NEMZEK, Jean A</au><au>EBONG, Samuel J</au><au>BOLGOS, Gerald R</au><au>NEWCOMB, David E</au><au>WOLLENBERG, Gordon K</au><au>REMICK, Daniel G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential local and systemic regulation of the murine chemokines KC and MIP2</atitle><jtitle>Shock (Augusta, Ga.)</jtitle><addtitle>Shock</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>15</volume><issue>4</issue><spage>278</spage><epage>284</epage><pages>278-284</pages><issn>1073-2322</issn><eissn>1540-0514</eissn><abstract>We characterized the relative biological activity and expression of two murine chemokines that may serve as functional homologues for human IL-8, KC, and macrophage inflammatory protein 2 (MIP2). Recombinant chemokines were produced in bacterial expression systems and antibodies specific for KC or MIP2 were raised. In vitro assays showed that KC elicited 4-fold greater neutrophil chemotaxis compared with MIP2, while MIP2 elicited significantly greater release of elastase. Lipopolysaccharide- (LPS) stimulated macrophages (8 h) secreted more MIP2 (approximately 10 ng/mL) compared with KC (approximately 4 ng/ml) and expression of either murine chemokine was independent of TNFalpha or IL-1beta production. Thioglycollate (thio) and glycogen (gly) induced peritonitis produced more KC (thio = 7.1 and gly = 2.5 ng/mL) in the peritoneum compared with MIP2 (thio = 4.5 and gly = 0.3 ng/mL). Plasma KC levels were very high after either challenge (approximately 24 ng/mL), which was &gt;50-fold more than the systemic increase in MIP2 (approximately 0.3 ng/mL). Our data demonstrate that while KC and MIP2 have similar in vitro production characteristics, KC appears to be a more potent and systemically distributed chemokine during acute in vivo inflammation, while MIP2 expression appears limited to localized expression.</abstract><cop>Augusta, GA</cop><pub>BioMedical Press</pub><pmid>11303726</pmid><doi>10.1097/00024382-200115040-00005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1073-2322
ispartof Shock (Augusta, Ga.), 2001-04, Vol.15 (4), p.278-284
issn 1073-2322
1540-0514
language eng
recordid cdi_crossref_primary_10_1097_00024382_200115040_00005
source Freely Accessible Journals
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Blotting, Western
Chemokine CXCL1
Chemokine CXCL2
Chemokines - genetics
Chemokines - metabolism
Chemokines - pharmacology
Chemokines, CXC
Chemotactic Factors - genetics
Chemotactic Factors - metabolism
Chemotactic Factors - pharmacology
Chemotaxis, Leukocyte - drug effects
Emergency and intensive care: infection, septic shock
Enzyme-Linked Immunosorbent Assay
Gene Expression Regulation
Glycogen - toxicity
Growth Substances - genetics
Growth Substances - metabolism
Growth Substances - pharmacology
Intensive care medicine
Intercellular Signaling Peptides and Proteins
Interleukin-6 - analysis
Leukocyte Elastase - secretion
Lipopolysaccharides - pharmacology
Macrophage Activation - drug effects
Macrophages, Peritoneal - secretion
Medical sciences
Mice
Mice, Inbred BALB C
Models, Animal
Neutrophils - drug effects
Peritonitis - chemically induced
Peritonitis - genetics
Peritonitis - immunology
Peritonitis - metabolism
Rabbits
Recombinant Fusion Proteins - pharmacology
Thioglycolates - toxicity
Tumor Necrosis Factor-alpha - analysis
title Differential local and systemic regulation of the murine chemokines KC and MIP2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A18%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20local%20and%20systemic%20regulation%20of%20the%20murine%20chemokines%20KC%20and%20MIP2&rft.jtitle=Shock%20(Augusta,%20Ga.)&rft.au=CALL,%20Douglas%20R&rft.date=2001-04-01&rft.volume=15&rft.issue=4&rft.spage=278&rft.epage=284&rft.pages=278-284&rft.issn=1073-2322&rft.eissn=1540-0514&rft_id=info:doi/10.1097/00024382-200115040-00005&rft_dat=%3Cpubmed_cross%3E11303726%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-8b8bb5daf07383f1e5ff3e8346558c958f7cdea92a4146a9da8a3779057348513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11303726&rfr_iscdi=true